|
| Exchange Disseminated Time | The Exchange has sought clarification from Natco Pharma Ltd with respect to disclosure submitted by the Company December 16, 2014 titled "Allotment of Equity Shares on Preferential Basis other than Cash"
Natco Pharma Ltd has been requested to submit its clarification to the Exchange with respect to the following in terms of Clause 36 of the Listing Agreement.
i. Issue period;
ii. Names of the investors and of these, which are promoters or promoter group entities,
iii. Post allotment of securities: -outcome of the subscription, issue price / allotted price (in case of convertibles), number of investors
The reply is awaited. |
|
|